Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1957 2
1963 1
1965 2
1967 3
1968 1
1969 3
1970 5
1971 4
1972 6
1973 5
1974 4
1975 1
1976 2
1977 5
1978 3
1979 2
1980 10
1981 7
1982 10
1983 11
1984 6
1985 7
1986 10
1987 4
1988 6
1989 4
1990 2
1991 4
1992 4
1993 4
1994 5
1995 6
1996 8
1997 12
1998 11
1999 19
2000 25
2001 16
2002 10
2003 14
2004 25
2005 25
2006 29
2007 28
2008 30
2009 40
2010 44
2011 73
2012 70
2013 80
2014 92
2015 93
2016 136
2017 111
2018 124
2019 141
2020 200
2021 208
2022 186
2023 157
2024 194
2025 174
2026 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,318 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
Wilson E, Goswami J, Baqui AH, Doreski PA, Perez-Marc G, Zaman K, Monroy J, Duncan CJA, Ujiie M, Rämet M, Pérez-Breva L, Falsey AR, Walsh EE, Dhar R, Wilson L, Du J, Ghaswalla P, Kapoor A, Lan L, Mehta S, Mithani R, Panozzo CA, Simorellis AK, Kuter BJ, Schödel F, Huang W, Reuter C, Slobod K, Stoszek SK, Shaw CA, Miller JM, Das R, Chen GL; ConquerRSV Study Group. Wilson E, et al. Among authors: kapoor a. N Engl J Med. 2023 Dec 14;389(24):2233-2244. doi: 10.1056/NEJMoa2307079. N Engl J Med. 2023. PMID: 38091530 Clinical Trial.
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.
Goswami J, Baqui AH, Doreski PA, Perez Marc G, Jimenez G, Ahmed S, Zaman K, Duncan CJA, Ujiie M, Rämet M, Pérez-Breva L, Lan L, Du J, Kapoor A, Mehta S, Tomassini JE, Huang W, Zhou H, Stoszek SK, Priddy F, Lin N, Le Cam N, Shaw CA, Slobod K, Wilson E, Miller JM, Das R. Goswami J, et al. Among authors: kapoor a. J Infect Dis. 2024 Nov 15;230(5):e996-e1006. doi: 10.1093/infdis/jiae316. J Infect Dis. 2024. PMID: 38889247 Free PMC article. Clinical Trial.
Intraoral Scanners: Mechanism, Applications, Advantages, and Limitations.
Dhull KS, Nagar R, Mathur P, Shil M, Jain S, Dureha R, Kapoor A. Dhull KS, et al. Among authors: kapoor a. J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S1929-S1931. doi: 10.4103/jpbs.jpbs_1299_23. Epub 2024 May 1. J Pharm Bioallied Sci. 2024. PMID: 39346446 Free PMC article. Review.
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer: A Randomized Clinical Trial.
Ostwal V, Patkar S, Engineer R, Parulekar M, Mandavkar S, Bhargava P, Srinivas S, Krishnatry R, Gudi S, Kapoor A, Pandey D, Patel S, Singhal A, Goel A, Dora TK, Chaudhary D, Chaugule D, Naughane D, Daddi A, Patil R, Ankathi SK, Ramaswamy A, Goel M. Ostwal V, et al. Among authors: kapoor a. JAMA Oncol. 2024 Aug 1;10(8):1116-1120. doi: 10.1001/jamaoncol.2024.1944. JAMA Oncol. 2024. PMID: 38958997 Free PMC article. Clinical Trial.
High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's disease.
Williams D, Glasstetter LM, Jong TT, Chen T, Kapoor A, Zhu S, Zhu Y, Calvo R, Gehrlein A, Wong K, Hogan AN, Vocadlo DJ, Jagasia R, Marugan JJ, Sidransky E, Henderson MJ, Chen Y. Williams D, et al. Among authors: kapoor a. Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2406009121. doi: 10.1073/pnas.2406009121. Epub 2024 Oct 10. Proc Natl Acad Sci U S A. 2024. PMID: 39388267 Free PMC article.
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.
Ostwal V, Ramaswamy A, Mandavkar S, Bhargava P, Naughane D, Sunn SF, Srinivas S, Kapoor A, Mishra BK, Gupta A, Sansar B, Pal V, Pandey A, Bonda A, Siripurapu I, Muddu VK, Kannan S, Chaugule D, Patil R, Parulekar M, Dhanawat A, Trikha M, Ghosh J, Noronha V, Menon N, Patil V, Prabhash K, Olver I. Ostwal V, et al. Among authors: kapoor a. JAMA Netw Open. 2024 Aug 1;7(8):e2426076. doi: 10.1001/jamanetworkopen.2024.26076. JAMA Netw Open. 2024. PMID: 39106066 Free PMC article. Clinical Trial.
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults.
Shaw CA, Essink B, Harper C, Mithani R, Kapoor A, Dhar R, Wilson L, Guo R, Panozzo CA, Wilson E, Simorellis AK, Reuter C, Stoszek SK, Chen GL, Das R, Goswami J. Shaw CA, et al. Among authors: kapoor a. J Infect Dis. 2024 Sep 23;230(3):e647-e656. doi: 10.1093/infdis/jiae081. J Infect Dis. 2024. PMID: 38385566 Free PMC article. Clinical Trial.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Méndez-Vidal MJ, Tjulandin S, Hoon Park S, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grünwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Alonso Gordoa T, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta CG. Choueiri TK, et al. Among authors: kapoor a. Lancet Oncol. 2023 Mar;24(3):228-238. doi: 10.1016/S1470-2045(23)00049-9. Lancet Oncol. 2023. PMID: 36858721 Clinical Trial.
Powassan Virus.
Kapoor AK, Zash R. Kapoor AK, et al. 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 34033361 Free Books & Documents.
2,318 results